JP2014523790A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014523790A5 JP2014523790A5 JP2014522838A JP2014522838A JP2014523790A5 JP 2014523790 A5 JP2014523790 A5 JP 2014523790A5 JP 2014522838 A JP2014522838 A JP 2014522838A JP 2014522838 A JP2014522838 A JP 2014522838A JP 2014523790 A5 JP2014523790 A5 JP 2014523790A5
- Authority
- JP
- Japan
- Prior art keywords
- balloon
- inflatable balloon
- textured
- textured inflatable
- organic polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- -1 fatty acid ester Chemical class 0.000 claims 11
- 239000003814 drug Substances 0.000 claims 10
- 229920000620 organic polymer Polymers 0.000 claims 9
- 229940124597 therapeutic agent Drugs 0.000 claims 9
- 239000003795 chemical substances by application Substances 0.000 claims 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 4
- 239000004952 Polyamide Substances 0.000 claims 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims 3
- 229930195729 fatty acid Natural products 0.000 claims 3
- 239000000194 fatty acid Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 229920002647 polyamide Polymers 0.000 claims 3
- 229920001707 polybutylene terephthalate Polymers 0.000 claims 3
- 229920000728 polyester Polymers 0.000 claims 3
- 229920000139 polyethylene terephthalate Polymers 0.000 claims 3
- 239000005020 polyethylene terephthalate Substances 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 claims 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 2
- 239000003146 anticoagulant agent Substances 0.000 claims 2
- 235000012000 cholesterol Nutrition 0.000 claims 2
- 150000005690 diesters Chemical class 0.000 claims 2
- 150000004665 fatty acids Chemical class 0.000 claims 2
- 239000003102 growth factor Substances 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- VEEGZPWAAPPXRB-BJMVGYQFSA-N (3e)-3-(1h-imidazol-5-ylmethylidene)-1h-indol-2-one Chemical group O=C1NC2=CC=CC=C2\C1=C/C1=CN=CN1 VEEGZPWAAPPXRB-BJMVGYQFSA-N 0.000 claims 1
- PUDHBTGHUJUUFI-SCTWWAJVSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 PUDHBTGHUJUUFI-SCTWWAJVSA-N 0.000 claims 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 claims 1
- BUROJSBIWGDYCN-GAUTUEMISA-N AP 23573 Chemical compound C1C[C@@H](OP(C)(C)=O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 BUROJSBIWGDYCN-GAUTUEMISA-N 0.000 claims 1
- 108010088751 Albumins Proteins 0.000 claims 1
- 102000009027 Albumins Human genes 0.000 claims 1
- 239000005528 B01AC05 - Ticlopidine Substances 0.000 claims 1
- 229940127291 Calcium channel antagonist Drugs 0.000 claims 1
- 229940123587 Cell cycle inhibitor Drugs 0.000 claims 1
- 229920002101 Chitin Polymers 0.000 claims 1
- 229920001661 Chitosan Polymers 0.000 claims 1
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- 229920002307 Dextran Polymers 0.000 claims 1
- 108010041308 Endothelial Growth Factors Proteins 0.000 claims 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 claims 1
- 108010056764 Eptifibatide Proteins 0.000 claims 1
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 claims 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
- 102000007625 Hirudins Human genes 0.000 claims 1
- 108010007267 Hirudins Proteins 0.000 claims 1
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 claims 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 claims 1
- 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 claims 1
- 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 claims 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims 1
- 102000029749 Microtubule Human genes 0.000 claims 1
- 108091022875 Microtubule Proteins 0.000 claims 1
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 claims 1
- 101001055320 Myxine glutinosa Insulin-like growth factor Proteins 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 229930012538 Paclitaxel Natural products 0.000 claims 1
- 229920002614 Polyether block amide Polymers 0.000 claims 1
- 239000004698 Polyethylene Substances 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 108010023197 Streptokinase Proteins 0.000 claims 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 1
- GSNOZLZNQMLSKJ-UHFFFAOYSA-N Trapidil Chemical compound CCN(CC)C1=CC(C)=NC2=NC=NN12 GSNOZLZNQMLSKJ-UHFFFAOYSA-N 0.000 claims 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 claims 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 229960000446 abciximab Drugs 0.000 claims 1
- 239000000556 agonist Substances 0.000 claims 1
- 229940121369 angiogenesis inhibitor Drugs 0.000 claims 1
- 239000004037 angiogenesis inhibitor Substances 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 230000001621 anti-mitogenic effect Effects 0.000 claims 1
- 230000000118 anti-neoplastic effect Effects 0.000 claims 1
- 230000001028 anti-proliverative effect Effects 0.000 claims 1
- 230000002785 anti-thrombosis Effects 0.000 claims 1
- 229940127219 anticoagulant drug Drugs 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 229940127218 antiplatelet drug Drugs 0.000 claims 1
- 239000000074 antisense oligonucleotide Substances 0.000 claims 1
- 238000012230 antisense oligonucleotides Methods 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 229920001400 block copolymer Polymers 0.000 claims 1
- 239000000480 calcium channel blocker Substances 0.000 claims 1
- 229960001338 colchicine Drugs 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 229940097362 cyclodextrins Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- GLGOPUHVAZCPRB-LROMGURASA-N eptifibatide Chemical compound N1C(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCCNC(=N)N)NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]1CC1=CN=C2[C]1C=CC=C2 GLGOPUHVAZCPRB-LROMGURASA-N 0.000 claims 1
- 229960004468 eptifibatide Drugs 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229960005167 everolimus Drugs 0.000 claims 1
- 238000001415 gene therapy Methods 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 230000012010 growth Effects 0.000 claims 1
- 239000003966 growth inhibitor Substances 0.000 claims 1
- 229960002897 heparin Drugs 0.000 claims 1
- 229920000669 heparin Polymers 0.000 claims 1
- 229940006607 hirudin Drugs 0.000 claims 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 229960002437 lanreotide Drugs 0.000 claims 1
- 108010021336 lanreotide Proteins 0.000 claims 1
- 229960004844 lovastatin Drugs 0.000 claims 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 claims 1
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 claims 1
- 229940124302 mTOR inhibitor Drugs 0.000 claims 1
- 239000003628 mammalian target of rapamycin inhibitor Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229960000485 methotrexate Drugs 0.000 claims 1
- 210000004688 microtubule Anatomy 0.000 claims 1
- 239000003226 mitogen Substances 0.000 claims 1
- 229960001592 paclitaxel Drugs 0.000 claims 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims 1
- 229920001308 poly(aminoacid) Polymers 0.000 claims 1
- 229920000570 polyether Polymers 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229920001855 polyketal Polymers 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 229960001302 ridaforolimus Drugs 0.000 claims 1
- 229960002930 sirolimus Drugs 0.000 claims 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims 1
- 230000008477 smooth muscle tissue growth Effects 0.000 claims 1
- 229960005202 streptokinase Drugs 0.000 claims 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 1
- 229960005001 ticlopidine Drugs 0.000 claims 1
- PHWBOXQYWZNQIN-UHFFFAOYSA-N ticlopidine Chemical compound ClC1=CC=CC=C1CN1CC(C=CS2)=C2CC1 PHWBOXQYWZNQIN-UHFFFAOYSA-N 0.000 claims 1
- 229960000187 tissue plasminogen activator Drugs 0.000 claims 1
- 229960000363 trapidil Drugs 0.000 claims 1
- 229960005356 urokinase Drugs 0.000 claims 1
- 229940124549 vasodilator Drugs 0.000 claims 1
- 239000003071 vasodilator agent Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/190,667 US20130030406A1 (en) | 2011-07-26 | 2011-07-26 | Textured Dilatation Balloon and Methods |
| US13/190,667 | 2011-07-26 | ||
| PCT/US2012/044722 WO2013015941A1 (en) | 2011-07-26 | 2012-06-28 | Textured dilatation balloon |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014523790A JP2014523790A (ja) | 2014-09-18 |
| JP2014523790A5 true JP2014523790A5 (https=) | 2015-08-13 |
Family
ID=46582058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014522838A Abandoned JP2014523790A (ja) | 2011-07-26 | 2012-06-28 | テクスチャ加工膨張バルーンおよび方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20130030406A1 (https=) |
| EP (1) | EP2736578A1 (https=) |
| JP (1) | JP2014523790A (https=) |
| CN (1) | CN103764218A (https=) |
| WO (1) | WO2013015941A1 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11229777B2 (en) | 2008-03-21 | 2022-01-25 | Cagent Vascular, Inc. | System and method for plaque serration |
| US9480826B2 (en) | 2008-03-21 | 2016-11-01 | Cagent Vascular, Llc | Intravascular device |
| EP2254641B1 (en) | 2008-03-21 | 2016-09-21 | Cagent Vascular, LLC | Device for pre-angioplasty serration and dilatation |
| WO2013134696A1 (en) * | 2012-03-09 | 2013-09-12 | Clearstream Technologies Limited | Parison for forming blow molded medical balloon with midified portion, medical balloon, and related methods |
| CN104936629A (zh) | 2012-10-26 | 2015-09-23 | 优敦力公司 | 用于非血管狭窄的药物涂层球囊导管 |
| US11938287B2 (en) | 2012-10-26 | 2024-03-26 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
| US10850076B2 (en) | 2012-10-26 | 2020-12-01 | Urotronic, Inc. | Balloon catheters for body lumens |
| US10806830B2 (en) | 2012-10-26 | 2020-10-20 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
| US10881839B2 (en) | 2012-10-26 | 2021-01-05 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
| US10898700B2 (en) | 2012-10-26 | 2021-01-26 | Urotronic, Inc. | Balloon catheters for body lumens |
| US11504450B2 (en) | 2012-10-26 | 2022-11-22 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
| WO2015035387A1 (en) * | 2013-09-09 | 2015-03-12 | Arsenal Medical, Inc. | Drug delivery systems and related methods |
| GB201404219D0 (en) * | 2014-03-08 | 2014-04-23 | Smiths Medical Int Ltd | Tracheostomy tube assemblies, inner cannulae and methods of manufacture |
| US10463842B2 (en) | 2014-06-04 | 2019-11-05 | Cagent Vascular, Llc | Cage for medical balloon |
| US10668257B2 (en) * | 2014-10-16 | 2020-06-02 | W. L. Gore & Associates, Inc. | Blow molded composite devices and methods |
| US10471238B2 (en) | 2014-11-03 | 2019-11-12 | Cagent Vascular, Llc | Serration balloon |
| CN118320191A (zh) | 2015-04-24 | 2024-07-12 | 优敦力公司 | 用于非血管狭窄的药物涂布的球囊导管 |
| US11904072B2 (en) | 2015-04-24 | 2024-02-20 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
| CN104921853A (zh) * | 2015-06-25 | 2015-09-23 | 四川大学华西医院 | 一种食管支撑装置 |
| CN113907835A (zh) | 2015-09-17 | 2022-01-11 | 开金血管公司 | 医用气囊的楔形切割器 |
| WO2018094077A1 (en) | 2016-11-16 | 2018-05-24 | Cagent Vascular, Llc | Systems and methods of depositing drug into tissue through serrations |
| CN106880876A (zh) * | 2017-02-24 | 2017-06-23 | 创领心律管理医疗器械（上海）有限公司 | 一种植入性医疗器械的抗菌涂层的制备方法 |
| CN108310594A (zh) * | 2018-03-14 | 2018-07-24 | 董鹏 | 一种球囊 |
| CN108187212B (zh) * | 2018-03-14 | 2022-07-15 | 董鹏 | 一种药物球囊 |
| CN112739406B (zh) | 2018-07-25 | 2024-12-24 | 开金血管公司 | 具有增强的推送性的医用气囊导管 |
| CN113727750B (zh) | 2019-02-22 | 2024-09-17 | 优敦力公司 | 用于体腔的药物涂布的球囊导管 |
| WO2021168284A1 (en) | 2020-02-21 | 2021-08-26 | GIE Medical, Inc. | Polymer-encapsulated drug particles |
| CN112743803A (zh) * | 2020-12-14 | 2021-05-04 | 武汉林溯科技有限公司 | 一种可替代压缩气体进行吹塑的吹塑模具 |
| CN115501457A (zh) * | 2022-05-17 | 2022-12-23 | 辽宁垠艺生物科技股份有限公司 | 一种表面微盲孔载药球囊制备工艺 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5049131A (en) * | 1989-05-31 | 1991-09-17 | Ashridge Ag | Balloon catheter |
| US5290306A (en) | 1989-11-29 | 1994-03-01 | Cordis Corporation | Puncture resistant balloon catheter |
| US5893840A (en) | 1991-01-04 | 1999-04-13 | Medtronic, Inc. | Releasable microcapsules on balloon catheters |
| ES2144419T3 (es) | 1991-07-05 | 2000-06-16 | Biocompatibles Ltd | Revestimientos polimericos de superficies. |
| US5500180A (en) | 1992-09-30 | 1996-03-19 | C. R. Bard, Inc. | Method of making a distensible dilatation balloon using a block copolymer |
| WO1994023787A1 (en) * | 1993-04-22 | 1994-10-27 | Rammler David H | Sampling balloon catheter |
| US6171278B1 (en) | 1994-03-02 | 2001-01-09 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
| US5891386A (en) * | 1997-04-25 | 1999-04-06 | Medtronic, Inc. | Method for making catheter balloons |
| US6306166B1 (en) | 1997-08-13 | 2001-10-23 | Scimed Life Systems, Inc. | Loading and release of water-insoluble drugs |
| US6786889B1 (en) * | 1999-03-31 | 2004-09-07 | Scimed Life Systems, Inc | Textured and/or marked balloon for stent delivery |
| NL1018018C2 (nl) * | 2001-05-08 | 2002-11-19 | Blue Medical Devices B V | Ballonkatheter en werkwijze voor het vervaardigen daarvan. |
| US20040143286A1 (en) * | 2003-01-17 | 2004-07-22 | Johnson Eric G. | Catheter with disruptable guidewire channel |
| WO2005016396A1 (en) | 2003-08-13 | 2005-02-24 | Poly-Med, Inc. | Biocompatible controlled release coatings for medical devices and related methods |
| US8088404B2 (en) | 2003-03-20 | 2012-01-03 | Medtronic Vasular, Inc. | Biocompatible controlled release coatings for medical devices and related methods |
| US20050118370A1 (en) | 2003-08-18 | 2005-06-02 | Medtronic Vascular, Inc. | Hyper-elastic, high strength dilatation balloon made from multi-block copolymers |
| US8048028B2 (en) * | 2005-02-17 | 2011-11-01 | Boston Scientific Scimed, Inc. | Reinforced medical balloon |
| US8795348B2 (en) * | 2005-06-14 | 2014-08-05 | Boston Scientific Scimed, Inc. | Medical devices and related methods |
| US20070298069A1 (en) | 2006-06-26 | 2007-12-27 | Boston Scientific Scimed, Inc. | Medical devices for release of low solubility therapeutic agents |
| US20080140002A1 (en) * | 2006-12-06 | 2008-06-12 | Kamal Ramzipoor | System for delivery of biologically active substances with actuating three dimensional surface |
| US8109904B1 (en) * | 2007-06-25 | 2012-02-07 | Abbott Cardiovascular Systems Inc. | Drug delivery medical devices |
| US8162880B2 (en) * | 2008-01-18 | 2012-04-24 | Swaminathan Jayaraman | Delivery of therapeutic and marking substance through intra lumen expansion of a delivery device |
| DE102008008926A1 (de) * | 2008-02-13 | 2009-08-20 | Biotronik Vi Patent Ag | System zum Einbringen einer intraluminalen Endoprothese und Verfahren zur Herstellung eines derartigen Systems |
| EP2594311A3 (en) | 2008-03-06 | 2013-07-10 | Boston Scientific Scimed, Inc. | Balloon catheter devices with sheath covering |
| JP5591103B2 (ja) * | 2008-03-12 | 2014-09-17 | アンジェスＭｇ株式会社 | 薬剤溶出型カテーテル及びその製造方法 |
| US20090254113A1 (en) * | 2008-04-04 | 2009-10-08 | Medtronic Vascular, Inc. | Dilatation balloon with ridges and methods |
| WO2010080575A2 (en) * | 2008-12-18 | 2010-07-15 | Michal Konstantino | Method and apparatus for transport of substances into body tissue |
| ES2550634T3 (es) * | 2009-07-10 | 2015-11-11 | Boston Scientific Scimed, Inc. | Uso de nanocristales para un balón de suministro de fármaco |
| EP2593170A1 (en) * | 2010-07-16 | 2013-05-22 | Abbott Cardiovascular Systems Inc. | Medical device having tissue engaging member and method for delivery of a therapeutic agent |
-
2011
- 2011-07-26 US US13/190,667 patent/US20130030406A1/en not_active Abandoned
-
2012
- 2012-06-28 CN CN201280036850.6A patent/CN103764218A/zh active Pending
- 2012-06-28 WO PCT/US2012/044722 patent/WO2013015941A1/en not_active Ceased
- 2012-06-28 JP JP2014522838A patent/JP2014523790A/ja not_active Abandoned
- 2012-06-28 EP EP12740245.1A patent/EP2736578A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014523790A5 (https=) | ||
| US20130030406A1 (en) | Textured Dilatation Balloon and Methods | |
| JP7309643B2 (ja) | バルーンアセンブリ | |
| RU2447901C2 (ru) | Медицинский продукт для лечения обтураций просветов организма и для предупреждения угрожающих повторных обтураций | |
| KR101550470B1 (ko) | 개선된 약제학적으로 코팅된 의약, 이의 제조 방법 및 이의 용도 | |
| ES2960088T3 (es) | Dispositivos de porosidad controlada para tratamientos de tejidos y métodos de fabricación | |
| AU2008210149B2 (en) | Biodegradable vascular support | |
| US8771332B2 (en) | Multi-layer balloon design for use in combination with catheter assemblies, and methods of making the same | |
| KR20110098612A (ko) | 생물학적 활성 물질을 포함하는 팽창가능한 생체적합성 코트 | |
| CN111107889B (zh) | 多次充胀式血管内医疗装置 | |
| CN102512747A (zh) | 药物洗脱球囊导管 | |
| WO2010136604A1 (en) | Transfer matrix for transferring a bioactive agent to body tissue | |
| WO2012122023A2 (en) | Eluting medical devices | |
| CN106456844B (zh) | 治疗下肢外周动脉疾病的方法 | |
| MX2009000090A (es) | Metodo, fabricacion y uso de productos medicos que liberan sustancia activa para mantener vasos sanguineos abiertos. | |
| RU2012157314A (ru) | Нанесения на эндопротез покрытия, состоящего из плотной сети полимерных волокон | |
| CN103800987B (zh) | 医用球囊及其制备方法 | |
| CN106456845A (zh) | 治疗下肢外周动脉疾病的方法 | |
| CN108778391A (zh) | 球囊导管及其制造方法以及处置方法 | |
| CN115120295B (zh) | 多次充胀式血管内医疗装置 | |
| JP6697917B2 (ja) | バルーンカテーテル及びその製造方法並びに処置方法 | |
| JP6697916B2 (ja) | バルーンカテーテル及びその製造方法並びに処置方法 | |
| JP6704273B2 (ja) | バルーンカテーテル及びその製造方法並びに処置方法 |